Reference SummaryAkamatsu Y, J Natl Cancer Inst 1974 Feb;52(2):377-85
Title |
Neoplasms and amyloidosis in strains of mice treated with 3-methylcholanthrene. |
Authors |
Akamatsu Y; Barton BP |
Journal |
J Natl Cancer Inst |
Volume |
52 |
Issue |
2 |
Year |
1974 |
Pages |
377-85 |
Abstract |
|
Links |
J:24686 – MGI References 4361176 – National Library of Medicine/PubMed |
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| BT/Os | Forestomach keratoacanthoma |
|
Forestomach |
12 - 15 |
|
| C57BL/6Os | Forestomach keratoacanthoma |
|
Forestomach |
0 - 2.4 |
|
| BALB/cOs | Forestomach keratoacanthoma |
|
Forestomach |
0 |
|
| C3HeB/Os | Forestomach keratoacanthoma |
|
Forestomach |
6.3 - 11 |
|
| C3H/HeOs | Forestomach keratoacanthoma |
|
Forestomach |
0 - 8.3 |
|
| BALB/cOs | Forestomach papilloma | Forestomach |
1.0 - 5.6 |
||
| BT/Os | Forestomach squamous cell carcinoma |
|
Forestomach |
5 - 31 |
|
| C57BL/6Os | Forestomach squamous cell carcinoma |
|
Forestomach |
0 |
|
| BALB/cOs | Forestomach squamous cell carcinoma |
|
Forestomach |
0 |
|
| C3HeB/Os | Forestomach squamous cell carcinoma |
|
Forestomach |
0 - 4.3 |
|
| C3H/HeOs | Forestomach squamous cell carcinoma |
|
Forestomach |
0 |
|
| BT/Os | Forestomach squamous cell papilloma |
|
Forestomach |
10 - 24 |
|
| C57BL/6Os | Forestomach squamous cell papilloma |
|
Forestomach |
13 - 20 |
|
| BALB/cOs | Forestomach squamous cell papilloma |
|
Forestomach |
11 - 14 |
|
| C3HeB/Os | Forestomach squamous cell papilloma |
|
Forestomach |
19 - 31 |
|
| C3H/HeOs | Forestomach squamous cell papilloma |
|
Forestomach |
12 - 17 |
|
| BT/Os | Forestomach tumor | Forestomach |
0 |
||
| C57BL/6Os | Forestomach tumor | Forestomach |
0 |
||
| C3HeB/Os | Forestomach tumor | Forestomach |
0 |
||
| C3H/HeOs | Forestomach tumor | Forestomach |
0 |
||
| BT/Os | Leukocyte leukemia | Leukocyte |
1.7 |
||
| BT/Os | Leukocyte lymphoma | Leukocyte |
4.3 |
||
| BT/Os | Leukocyte lymphoma |
|
Leukocyte |
0 - 5 |
|
| C57BL/6Os | Leukocyte lymphoma | Leukocyte |
2.5 - 5.6 |
||
| C57BL/6Os | Leukocyte lymphoma |
|
Leukocyte |
11 - 25 |
|
| BALB/cOs | Leukocyte lymphoma | Leukocyte |
5.6 - 13 |
||
| BALB/cOs | Leukocyte lymphoma |
|
Leukocyte |
31 - 47 |
|
| C3HeB/Os | Leukocyte lymphoma | Leukocyte |
4.9 - 6.2 |
||
| C3HeB/Os | Leukocyte lymphoma |
|
Leukocyte |
3.1 - 5.7 |
|
| C3H/HeOs | Leukocyte lymphoma | Leukocyte |
0 - 1.2 |
||
| C3H/HeOs | Leukocyte lymphoma |
|
Leukocyte |
4.2 - 9.3 |
|
| BT/Os | Liver hepatoma | Liver |
1.1 - 11 |
||
| BT/Os | Liver hepatoma |
|
Liver |
0 - 3.9 |
|
| C57BL/6Os | Liver hepatoma | Liver |
0 - 10 |
||
| C57BL/6Os | Liver hepatoma |
|
Liver |
0 - 1.2 |
|
| BALB/cOs | Liver hepatoma | Liver |
0 - 1.9 |
||
| BALB/cOs | Liver hepatoma |
|
Liver |
2.4 - 2.8 |
|
| C3HeB/Os | Liver hepatoma | Liver |
0 - 18 |
||
| C3HeB/Os | Liver hepatoma |
|
Liver |
0 - 2.9 |
|
| C3H/HeOs | Liver hepatoma | Liver |
0 - 34 |
||
| C3H/HeOs | Liver hepatoma |
|
Liver |
0 - 4.2 |
|
| BT/Os | Lung - Alveolus adenoma | Lung - Alveolus |
1.1 - 2.2 |
||
| BT/Os | Lung - Alveolus adenoma |
|
Lung - Alveolus |
3.9 |
|
| C57BL/6Os | Lung - Alveolus adenoma |
|
Lung - Alveolus |
1.2 - 5 |
|
| BALB/cOs | Lung - Alveolus adenoma |
|
Lung - Alveolus |
50 - 62 |
|
| BALB/cOs | Lung - Alveolus adenoma | Lung - Alveolus |
1.0 |
||
| C3HeB/Os | Lung - Alveolus adenoma |
|
Lung - Alveolus |
2.9 |
|
| C3HeB/Os | Lung - Alveolus adenoma | Lung - Alveolus |
3.1 |
||
| BT/Os | Lung adenoma |
|
Lung |
0 |
|
| C57BL/6Os | Lung adenoma | Lung |
0 |
||
| BALB/cOs | Lung adenoma | Lung |
0 |
||
| C3HeB/Os | Lung adenoma | Lung |
0 |
||
| C3HeB/Os | Lung adenoma |
|
Lung |
0 |
|
| C3H/HeOs | Lung adenoma | Lung |
0 |
||
| C3H/HeOs | Lung adenoma |
|
Lung |
0 - 4.2 |
|
| BT/Os | Mammary gland tumor | Mammary gland |
70 |
||
| BT/Os | Mammary gland tumor |
|
Mammary gland |
85 |
|
| C57BL/6Os | Mammary gland tumor | Mammary gland |
0 |
||
| C57BL/6Os | Mammary gland tumor |
|
Mammary gland |
0 |
|
| BALB/cOs | Mammary gland tumor | Mammary gland |
12 |
||
| BALB/cOs | Mammary gland tumor |
|
Mammary gland |
24 |
|
| C3HeB/Os | Mammary gland tumor | Mammary gland |
2.1 |
||
| C3HeB/Os | Mammary gland tumor |
|
Mammary gland |
6.3 |
|
| C3H/HeOs | Mammary gland tumor | Mammary gland |
96 |
||
| C3H/HeOs | Mammary gland tumor |
|
Mammary gland |
93 |
|
| BT/Os | Ovary tumor | Ovary |
1.7 |
||
| BT/Os | Ovary tumor |
|
Ovary |
0 |
|
| C57BL/6Os | Ovary tumor | Ovary |
0 |
||
| C57BL/6Os | Ovary tumor |
|
Ovary |
0 |
|
| BALB/cOs | Ovary tumor | Ovary |
3.8 |
||
| BALB/cOs | Ovary tumor |
|
Ovary |
4.8 |
|
| C3HeB/Os | Ovary tumor | Ovary |
2.1 |
||
| C3HeB/Os | Ovary tumor |
|
Ovary |
12.5 |
|
| C3H/HeOs | Ovary tumor | Ovary |
0 |
||
| C3H/HeOs | Ovary tumor |
|
Ovary |
0 |
|
| BT/Os | Skin tumor | Skin |
1.1 - 2.2 |
||
| BT/Os | Skin tumor |
|
Skin |
3.9 - 5 |
|
| C57BL/6Os | Skin tumor | Skin |
0 |
||
| C57BL/6Os | Skin tumor |
|
Skin |
3.5 - 5 |
|
| BALB/cOs | Skin tumor | Skin |
0 - 3.8 |
||
| BALB/cOs | Skin tumor |
|
Skin |
2.4 - 2.8 |
|
| C3HeB/Os | Skin tumor | Skin |
0 |
||
| C3HeB/Os | Skin tumor |
|
Skin |
0 - 6.3 |
|
| C3H/HeOs | Skin tumor | Skin |
0 |
||
| C3H/HeOs | Skin tumor |
|
Skin |
0 - 8.3 |
|
| BT/Os | Urinary bladder squamous cell carcinoma |
|
Urinary bladder |
3.9 |
|
| BT/Os | Urinary bladder tumor | Urinary bladder |
0 |
||
| BT/Os | Urinary bladder tumor |
|
Urinary bladder |
0 |
|
| C57BL/6Os | Urinary bladder tumor | Urinary bladder |
0 |
||
| C57BL/6Os | Urinary bladder tumor |
|
Urinary bladder |
0 |
|
| BALB/cOs | Urinary bladder tumor | Urinary bladder |
0 |
||
| BALB/cOs | Urinary bladder tumor |
|
Urinary bladder |
0 |
|
| C3HeB/Os | Urinary bladder tumor | Urinary bladder |
0 |
||
| C3HeB/Os | Urinary bladder tumor |
|
Urinary bladder |
0 |
|
| C3H/HeOs | Urinary bladder tumor | Urinary bladder |
0 |
||
| C3H/HeOs | Urinary bladder tumor |
|
Urinary bladder |
0 |